Agencies
... Read More
By clicking “Accept All Cookies”, you agree to the storing of cookies on your device to enhance site navigation, analyze site usage, and assist in our marketing efforts. Cookie Policy.
Written By: Agencies | Published : April 4, 2015 12:54 PM IST
In Parkinson's disease new symptoms gradually develop over time and the initial symptoms become more difficult to control. An implant of stem cells treated with an anti-cancer drug has been found to be effective against Parkinson's symptoms in mice. The findings published in the journal Frontiers in Cellular Neuroscience could be an important step toward using the implantation of stem cell-generated neurons as a treatment for Parkinson's disease in humans. Here is all you need to know about Parkinson's disease.
Using a US Food and Drug Administration (FDA)-approved anti-cancer drug, the researchers were able to grow dopamine-producing neurons derived from embryonic stem cells that remained healthy and functional for as long as 15 months after implantation into mice, restoring motor function without forming tumours.
'This simple strategy of shortly exposing pluripotent stem cells to an anti-cancer drug turned the transplant safer, by eliminating the risk of tumour formation', said the leader of the study Stevens Rehen, professor at the Federal University of Rio de Janeiro (UFRJ) in Brazil. Parkinson's, which affects as many as 10 million people in the world, is caused by a depletion of dopamine-producing neurons in the brain.
Several studies have indicated that the transplantation of embryonic stem cells improves motor functions in animal models. However, until now, the procedure was shown to be unsafe because of the risk of tumours upon transplantation. To address this issue, the researchers for the first time pre-treated undifferentiated mouse embryonic stem cells with mitomycin C, a drug already prescribed to treat cancer. The substance blocks the DNA replication and prevents the cells from multiplying out of control. According to another research, cinnamon may held progression of the disease.
The researchers used mice modelled for Parkinson's. Unlike the control group, animals receiving the treated stem cells showed improvement in Parkinson's symptoms and survived until the end of these observation period of 12 weeks post-transplant with no tumours detected. Four of these mice were monitored for as long as 15 months with no signs of pathology.
Furthermore, the scientists have also shown that treating the stem cells with mitomycin C induced a four-fold increase in the release of dopamine after in vitro differentiation.
Source: IANS
Image source: Getty Images
For more articles on diseases & conditions, visit our diseases & conditions section. For daily free health tips, sign up for our newsletter.
Disclaimer: The content on TheHealthSite.com is only for informational purposes. It is not at all professional medical advice. Always consult your doctor or a healthcare specialist for any questions regarding your health or a medical condition.